Agenus Inc (AGEN)

04:15 AM

Armen of Agenus (NASDAQ: AGEN) takes salary in stock - stocktitan.net

04:15 AM

01:47 AM

Agenus (AGEN) presents new phase 1b clinical data on BOT/BAL combination for MSS mCRC - MSN

01:47 AM

Apr 05, 2026

New Phase II Data on BOT/BAL Combination in Gastroesophageal Cancer at AACR 2026Agenus - Oncodaily

Apr 05, 2026

Apr 05, 2026

Agenus receives $20M payment under Zydus Life Sciences collaboration - MSN

Apr 05, 2026

Apr 05, 2026

Buybacks Report: How sensitive is Agenus Inc to inflation2026 Sector Moves & AI Based Trade Execution Alerts - baoquankhu1.vn

Apr 05, 2026

Apr 05, 2026

Setup Watch: Can Agenus Inc deliver consistent EPS growth2026 Biggest Moves & Expert Approved Momentum Trade Ideas - baoquankhu1.vn

Apr 05, 2026

Apr 04, 2026

Weekly Earnings: Should you avoid Agenus Inc stock right nowPortfolio Performance Report & Risk Controlled Stock Pick Alerts - baoquankhu1.vn

Apr 04, 2026

Apr 04, 2026

Everything Important About Agenus (AGEN) Receiving a Strong Buy Rating Upgrade - Bitget

Apr 04, 2026

Apr 03, 2026

Agenus unveils Phase II data for BOT BAL and MiNK iNKT therapy in PD-1 refractory cancer - Traders Union

Apr 03, 2026

Apr 03, 2026

Can Agenus (AGEN) Run Higher on Rising Earnings Estimates? - Yahoo Finance

Apr 03, 2026

Apr 03, 2026

All You Need to Know About Agenus (AGEN) Rating Upgrade to Strong Buy - Yahoo Finance

Apr 03, 2026

Apr 03, 2026

Why Agenus (AGEN) is a Top Momentum Stock for the Long-Term - Yahoo Finance

Apr 03, 2026

Apr 03, 2026

Has Agenus (AGEN) Outpaced Other Medical Stocks This Year? - Yahoo Finance

Apr 03, 2026

Apr 03, 2026

Phase 3 BATTMAN Trial Launches BOT/BAL in MSS or pMMR Metastatic Colorectal Cancer - Oncodaily

Apr 03, 2026

Apr 03, 2026

Agenus Announces Data from Phase II Study of BOT+BAL in Combination with agent-797 in PD-1 Refractory Gastroesophageal Cancer to be Presented at AACR 2026 - The AI Journal

Apr 03, 2026

Apr 03, 2026

HC Wainwright Analysts Boost Earnings Estimates for Agenus - MarketBeat

Apr 03, 2026

Apr 02, 2026

Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial of BOT+BAL Immunotherapy Combination in MSS or pMMR Metastatic Colorectal Cancer - 뉴스와이어

Apr 02, 2026

Apr 02, 2026

Has Agenus (AGEN) Surpassed Other Healthcare Stocks So Far This Year? - Bitget

Apr 02, 2026

Apr 02, 2026

Agenus Inc. (AGEN) stock price, news, quote and history - Yahoo Finance UK

Apr 02, 2026

Apr 02, 2026

Agenus (NASDAQ: AGEN) director awarded 2,448 Deferred Stock Units as board pay - stocktitan.net

Apr 02, 2026

Apr 02, 2026

Agenus Inc. Initiates Landmark Phase 3 BATTMAN Trial In MSS Metastatic Colorectal Cancer - BioPharma APAC

Apr 02, 2026

Apr 02, 2026

Portfolio Update: Is Agenus Inc benefiting from interest rate changes2026 Final Week & Weekly Watchlist for Consistent Profits - baoquankhu1.vn

Apr 02, 2026

Apr 01, 2026

Agenus begins phase 3 trial for colorectal cancer treatment By Investing.com - Investing.com Australia

Apr 01, 2026

Apr 01, 2026

Agenus Enrolls First Patient in Phase 3 BATTMAN Trial for MSS/pMMR Metastatic Colorectal Cancer - Oncodaily

Apr 01, 2026

Apr 01, 2026

Agenus (AGEN) Launches Global Phase 3 Trial for Innovative Cance - GuruFocus

Apr 01, 2026

Apr 01, 2026

Agenus (AGEN) Launches Global Phase 3 Trial for Innovative Cancer Treatment - GuruFocus

Apr 01, 2026

Apr 01, 2026

Agenus Inc Announces First Patient Enrolled In Global Phase 3 BATTMAN Trial Of BOT Plus BAL Immunotherapy Combination In MSS Or PMMR Metastatic Colorectal Cancer - marketscreener.com

Apr 01, 2026

Apr 01, 2026

Can Agenus' BOT + BAL Immunotherapy Turn Cold Tumors Hot? - RTTNews

Apr 01, 2026

Apr 01, 2026

Agenus Launches Landmark Global Phase 3 Clinical Trial - Intellectia AI

Apr 01, 2026

Apr 01, 2026

Agenus begins phase 3 trial for colorectal cancer treatment - Investing.com

Apr 01, 2026

Apr 01, 2026

Agenus starts global colorectal cancer study for patients with few options - stocktitan.net

Apr 01, 2026

Mar 31, 2026

Agenus AGM: Bot/Bal Combo Targets “Cold” MSS Colorectal Cancer as Phase III BATMAN Trial Launches - Yahoo Finance

Mar 31, 2026

Mar 31, 2026

Agenus announced that the first patient has been enrolled in its global Phase III Battman trial. - Bitget

Mar 31, 2026

Mar 29, 2026

Agenus (NASDAQ:AGEN) Downgraded to "Hold" Rating by Wall Street Zen - marketbeat.com

Mar 29, 2026

Mar 28, 2026

Webcast on Clinical Progress and Global Access Initiatives Set for March 31 – Agenus - oncodaily.com

Mar 28, 2026

Mar 27, 2026

Agenus Cervical Cancer Trial Terminated: What RaPiDS Means for AGEN Investors - tipranks.com

Mar 27, 2026

Mar 27, 2026

Agenus Inc. (NASDAQ:AGEN) Given Consensus Rating of "Hold" by Brokerages - MarketBeat

Mar 27, 2026

Mar 27, 2026

Agenus Securities Class Action Dismissed, Legal Risks Ease - tipranks.com

Mar 27, 2026

Mar 27, 2026

Agenus to Host March 2026 Stakeholder Webcast Harnessing the Immune System to Advance BOT + BAL Across Tumor Types and Expand Patient Access - BioSpace

Mar 27, 2026

Mar 26, 2026

Agenus Q4 2025 earnings preview - MSN

Mar 26, 2026

Mar 26, 2026

[SCHEDULE 13G/A] AGENU... - Stock Titan

Mar 26, 2026

Mar 26, 2026

Agenus reports dismissal of securities class action lawsuit in Massachusetts By Investing.com - Investing.com South Africa

Mar 26, 2026

Mar 26, 2026

Agenus reports dismissal of securities class action lawsuit in Massachusetts - Investing.com

Mar 26, 2026

Mar 26, 2026

Agenus wins dismissal of securities class action in Massachusetts federal court - TradingView

Mar 26, 2026

Mar 26, 2026

Court dismisses Agenus (AGEN) securities class action, siding with executives - Stock Titan

Mar 26, 2026

Mar 25, 2026

Agenus Secures Dismissal of Investors’ Cancer Drug Class Action - Bloomberg Law News

Mar 25, 2026

Mar 24, 2026

Agenus Escapes Investor Fraud Suit Over Cancer Drug - Law360

Mar 24, 2026